Call for collaborations
Hopital Necker (Paris, France) seeks collaboration with centres following patients with...
-Congenital, isolated asplenia (without heart malformation)
-Chronic muco-cutaneous candidiasis (CMCC) without auto-immunity
-Classic, Mediterranean Kaposi’s sarcoma of childhood (caused by HHV-8)
-Invasive, isolated and unexplained staphylococcal disease
-Severe viral illnesses in otherwise healthy children (adenovirus, varicella-zoster, etc.)
read more....
February 11, 2008
Prior to the next General Assembly, which will take place at the Biennial Meeting in 's-Hertogenbosch in the Netherlands, the ESID members will be asked to cast an electronic vote for the ESID board. We will post incoming applications in the News section of the ESID website. Please keep checking this section for news.
More informationDear Members,
The new application for SCIg to be included in the EML for Children is up on the WHO website
http://mednet3.who.int/EML/expcom/CHILDREN/INDEX_children_07.htm
I would be glad if we could get some additional support - it was very successful last time when we achieved IVIg on the Essential Medicines list in March of this year. We need help again please - especially from paediatricians and those looking after adolescents too.
We need data on safety , efficacy and cost-effectiveness of SCIg in children and in adults please. The paucity of data, compared with IVIg, was the reason that SCIg did not make the main list in March - so here is a chance to get the EML committee to see that too.
The IUIS committee, on whose behalf I have sent this application, and IPOPI have been very helpful. If you can think of anyone else who could add some info and data - please do send this on.
very many thanks
Helen Chapel
